teva pharmaceuticals introduces the first generic glp-1 for weight loss Wegovy Pill Wins FDA Approval as Oral Treatment Obesity and Generic Liraglutide Approved, Marking First

Hales C, Carroll M, Fryar CD, et al

Disclosures R.J.J.: none

Of particular note, as someone at the conference asked about the cardiac side effects reported in both trials, the presenters were quick to note the cardiac events were sinus tachycardia, ventricular extrasystoles noted on EKG(aka PVCs, something common and usually of no concern) and a couple patients reporting palpitations

We dont have a disease of obesity

The angiotensin-converting enzyme (ACE), secreted by lung and kidney, converts ANG I to ANG II, whereas the angiotensin-converting enzyme 2 (ACE2) further cleaves ANG II to ANG (1,7)

And dont forget the four-figure monthly side effect on the wallet if GLP-1s need to be paid for out of pocket